Aleksey Gavrilov

Aleksey Gavrilov

Aleksey Gavrilov
Recent work

Aleksey Gavrilov is an Attorney of ALRUD Law Firm’s Tax Practice. Aleksey advises Russian and foreign companies on a wide range of tax law issues, arising in corporate, commercial, IP and labor practice projects. He has significant experience in preparation of tax returns and various notifications under CFC and currency legislation for HNWIs.

Aleksey joined ALRUD in 2018, after graduation with honors from Lomonosov Moscow State University, Department of Law, specializing in financial law.

In 2020, he received his master’s degree in jurisprudence (specialization “Tax administration, tax consulting and protection of taxpayer rights”).

Include advising

The French producer of turbomachinery equipment

intended to install diesel generators and supervise their launch at the largest nuclear power plant in Russia on permanent establishment risks.

One of the leading Russian hosting providers and domain name registrars

on VAT issues arising under a new innovative business model.

JV of two Russian petrochemical companies

on their project aimed at incorporation of a trading company and logistics hub in Europe, for selling chemical industry products to the European and Latin America markets.

One of the largest commercial banks in Russia

intended to take part in the unique project connected with construction and maintenance of the railway infrastructure for the bridge, situated at Russian-Chinese state border (applicability of regional tax incentives, special investment regimes, etc.).

The Russian subsidiary of the multinational pharmaceutical company

with complex tax due diligence of two competing businesses that were merged with the client.

One of the largest Russian agro-industrial companies

on tax aspects of the intra-group transfer of a key trademark that was a part of the group’s global restructuring process.

One of the leading associations of the pharmaceutical companies in Russia

on tax risks arising from its historic structure of interacting with the drug manufacturers and the pharmacy chains.

We use cookies to offer better performance of the website and fulfill some other purposes specified in the Privacy Policy. By way of ticking the box you provide your consent to use of cookies. Otherwise, we will only use technical cookies, which are necessary for proper functioning of the website.